Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model

Abstract excerpt

Abstract Progressive familial intrahepatic cholestasis type 3 (PFIC3) is a rare monogenic disease caused by mutations in the ABCB4 gene, resulting in a reduction in biliary phosphatidylcholine. Reduced biliary phosphatidylcholine cannot counteract the detergent effects of bile salts, leading to cholestasis, cholangitis, cirrhosis and ultimately liver failure. Here, we report results from treating two- or...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Transport and Resistance Mechanisms
• Share to Hepatitis B Virus Studies
• Share to Pediatric Hepatobiliary Diseases and Treatments